

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 5.55701165 |
| 2 | hemidesmosome assembly (GO:0031581) | 5.43825836 |
| 3 | nuclear pore organization (GO:0006999) | 5.11554898 |
| 4 | regulation of mitotic spindle organization (GO:0060236) | 4.37328539 |
| 5 | cell adhesion mediated by integrin (GO:0033627) | 4.18165367 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.05625973 |
| 7 | pore complex assembly (GO:0046931) | 3.96545333 |
| 8 | locomotory exploration behavior (GO:0035641) | 3.95566569 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 3.65897649 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.65897649 |
| 11 | mitotic sister chromatid cohesion (GO:0007064) | 3.54060038 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.46797043 |
| 13 | layer formation in cerebral cortex (GO:0021819) | 3.45424103 |
| 14 | desmosome organization (GO:0002934) | 3.36861867 |
| 15 | skin morphogenesis (GO:0043589) | 3.36653533 |
| 16 | collagen fibril organization (GO:0030199) | 3.35455650 |
| 17 | glutamate secretion (GO:0014047) | 3.34841136 |
| 18 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.33990919 |
| 19 | L-phenylalanine metabolic process (GO:0006558) | 3.33784750 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.33784750 |
| 21 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.29271222 |
| 22 | cell-substrate junction assembly (GO:0007044) | 3.24337287 |
| 23 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.24034427 |
| 24 | Golgi transport vesicle coating (GO:0048200) | 3.21462768 |
| 25 | COPI coating of Golgi vesicle (GO:0048205) | 3.21462768 |
| 26 | cellular ketone body metabolic process (GO:0046950) | 3.19143573 |
| 27 | synaptic vesicle exocytosis (GO:0016079) | 3.18607245 |
| 28 | vocalization behavior (GO:0071625) | 3.11702972 |
| 29 | endodermal cell differentiation (GO:0035987) | 3.09427928 |
| 30 | activation of protein kinase A activity (GO:0034199) | 3.04484797 |
| 31 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.03355959 |
| 32 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.01965973 |
| 33 | regulation of spindle organization (GO:0090224) | 3.01604759 |
| 34 | alpha-linolenic acid metabolic process (GO:0036109) | 3.00096376 |
| 35 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.99165489 |
| 36 | COPII vesicle coating (GO:0048208) | 2.98329377 |
| 37 | aromatic amino acid family catabolic process (GO:0009074) | 2.97886129 |
| 38 | glutamate metabolic process (GO:0006536) | 2.96869931 |
| 39 | mitotic chromosome condensation (GO:0007076) | 2.96711541 |
| 40 | hypotonic response (GO:0006971) | 2.94641073 |
| 41 | protein localization to endosome (GO:0036010) | 2.93956070 |
| 42 | exploration behavior (GO:0035640) | 2.92786313 |
| 43 | neurotransmitter secretion (GO:0007269) | 2.91601153 |
| 44 | negative regulation of fibrinolysis (GO:0051918) | 2.90590056 |
| 45 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.90016712 |
| 46 | cytoskeleton-dependent cytokinesis (GO:0061640) | 2.87441987 |
| 47 | nucleobase catabolic process (GO:0046113) | 2.85140489 |
| 48 | ribosome assembly (GO:0042255) | 2.84872422 |
| 49 | mitotic cytokinesis (GO:0000281) | 2.84493854 |
| 50 | lens morphogenesis in camera-type eye (GO:0002089) | 2.83743128 |
| 51 | chondrocyte proliferation (GO:0035988) | 2.83169555 |
| 52 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.83092502 |
| 53 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.80589541 |
| 54 | ketone body metabolic process (GO:1902224) | 2.78974548 |
| 55 | gamma-aminobutyric acid transport (GO:0015812) | 2.78658684 |
| 56 | bile acid biosynthetic process (GO:0006699) | 2.73262874 |
| 57 | kynurenine metabolic process (GO:0070189) | 2.72660881 |
| 58 | protein hydroxylation (GO:0018126) | 2.71222824 |
| 59 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.70320275 |
| 60 | vesicle transport along microtubule (GO:0047496) | 2.68322249 |
| 61 | protein targeting to Golgi (GO:0000042) | 2.67659385 |
| 62 | complement activation, alternative pathway (GO:0006957) | 2.66942039 |
| 63 | vesicle coating (GO:0006901) | 2.65809539 |
| 64 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.65235958 |
| 65 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.64979493 |
| 66 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.64965635 |
| 67 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.64840019 |
| 68 | regulation of synaptic vesicle transport (GO:1902803) | 2.64776279 |
| 69 | regulation of fibrinolysis (GO:0051917) | 2.64745834 |
| 70 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.62789489 |
| 71 | glyoxylate metabolic process (GO:0046487) | 2.62469513 |
| 72 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.60452469 |
| 73 | protein carboxylation (GO:0018214) | 2.60452469 |
| 74 | cellular potassium ion homeostasis (GO:0030007) | 2.58544955 |
| 75 | lysine catabolic process (GO:0006554) | 2.56662292 |
| 76 | lysine metabolic process (GO:0006553) | 2.56662292 |
| 77 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.56238449 |
| 78 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.54845552 |
| 79 | urea cycle (GO:0000050) | 2.54467773 |
| 80 | urea metabolic process (GO:0019627) | 2.54467773 |
| 81 | cysteine metabolic process (GO:0006534) | 2.53622984 |
| 82 | coenzyme catabolic process (GO:0009109) | 2.53410669 |
| 83 | regulation of RNA export from nucleus (GO:0046831) | 2.52112532 |
| 84 | regulation of protein activation cascade (GO:2000257) | 2.51594925 |
| 85 | dendritic spine morphogenesis (GO:0060997) | 2.51435876 |
| 86 | negative regulation of stem cell proliferation (GO:2000647) | 2.51255718 |
| 87 | dendrite morphogenesis (GO:0048813) | 2.51086812 |
| 88 | glycoprotein catabolic process (GO:0006516) | 2.50678187 |
| 89 | morphogenesis of an epithelial sheet (GO:0002011) | 2.50550393 |
| 90 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.50463476 |
| 91 | clathrin coat assembly (GO:0048268) | 2.50449572 |
| 92 | sodium ion export (GO:0071436) | 2.49879311 |
| 93 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.49719685 |
| 94 | neuron cell-cell adhesion (GO:0007158) | 2.49061825 |
| 95 | polyol transport (GO:0015791) | 2.48782588 |
| 96 | establishment of protein localization to Golgi (GO:0072600) | 2.48100978 |
| 97 | protein localization to synapse (GO:0035418) | 2.46444866 |
| 98 | proline transport (GO:0015824) | 2.45299994 |
| 99 | axon extension (GO:0048675) | 2.44857854 |
| 100 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.44143428 |
| 101 | neuronal action potential propagation (GO:0019227) | 2.44054038 |
| 102 | organelle transport along microtubule (GO:0072384) | 2.42966247 |
| 103 | regulation of cholesterol homeostasis (GO:2000188) | 2.42347097 |
| 104 | extracellular matrix assembly (GO:0085029) | 2.41301089 |
| 105 | DNA topological change (GO:0006265) | 2.40637985 |
| 106 | regulation of synapse structural plasticity (GO:0051823) | 2.40186475 |
| 107 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.39885191 |
| 108 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.39774763 |
| 109 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.39010040 |
| 110 | cellular protein complex localization (GO:0034629) | 2.38945754 |
| 111 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.38010237 |
| 112 | neuron recognition (GO:0008038) | 2.37901035 |
| 113 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.37555753 |
| 114 | regulation of complement activation (GO:0030449) | 2.37054779 |
| 115 | mating behavior (GO:0007617) | 2.36577205 |
| 116 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.35973959 |
| 117 | neuromuscular process controlling balance (GO:0050885) | 2.35970101 |
| 118 | DNA synthesis involved in DNA repair (GO:0000731) | 2.35400385 |
| 119 | acylglycerol catabolic process (GO:0046464) | 2.34946631 |
| 120 | neutral lipid catabolic process (GO:0046461) | 2.34946631 |
| 121 | endoplasmic reticulum organization (GO:0007029) | 2.34824271 |
| 122 | indole-containing compound catabolic process (GO:0042436) | 2.34696075 |
| 123 | indolalkylamine catabolic process (GO:0046218) | 2.34696075 |
| 124 | tryptophan catabolic process (GO:0006569) | 2.34696075 |
| 125 | high-density lipoprotein particle remodeling (GO:0034375) | 2.34447029 |
| 126 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.33294808 |
| 127 | peptidyl-proline hydroxylation (GO:0019511) | 2.32468228 |
| 128 | regulation of protein export from nucleus (GO:0046825) | 2.31812429 |
| 129 | regulation of ARF protein signal transduction (GO:0032012) | 2.31327536 |
| 130 | localization within membrane (GO:0051668) | 2.30177663 |
| 131 | neuron projection extension (GO:1990138) | 2.29469923 |
| 132 | bile acid metabolic process (GO:0008206) | 2.29296030 |
| 133 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.29013686 |
| 134 | drug transmembrane transport (GO:0006855) | 2.29008220 |
| 135 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.28893933 |
| 136 | cellular modified amino acid catabolic process (GO:0042219) | 2.28851097 |
| 137 | negative regulation of anoikis (GO:2000811) | 2.28680136 |
| 138 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.27878356 |
| 139 | proximal/distal pattern formation (GO:0009954) | 2.27835881 |
| 140 | dosage compensation (GO:0007549) | 2.27352030 |
| 141 | protein export from nucleus (GO:0006611) | 2.27083990 |
| 142 | glutamate receptor signaling pathway (GO:0007215) | 2.26935625 |
| 143 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.26663377 |
| 144 | kidney mesenchyme development (GO:0072074) | 2.26108423 |
| 145 | dicarboxylic acid catabolic process (GO:0043649) | 2.25970501 |
| 146 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.25957812 |
| 147 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.25787716 |
| 148 | cellular response to vitamin D (GO:0071305) | 2.25520587 |
| 149 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.25174858 |
| 150 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.23835076 |
| 151 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.23451360 |
| 152 | regulation of dendritic spine development (GO:0060998) | 2.23073213 |
| 153 | suckling behavior (GO:0001967) | 2.22661689 |
| 154 | cerebellar granule cell differentiation (GO:0021707) | 2.21944833 |
| 155 | cerebral cortex cell migration (GO:0021795) | 2.21937848 |
| 156 | pre-miRNA processing (GO:0031054) | 2.21565844 |
| 157 | axonal fasciculation (GO:0007413) | 2.21177085 |
| 158 | embryonic process involved in female pregnancy (GO:0060136) | 2.20892351 |
| 159 | acetyl-CoA metabolic process (GO:0006084) | 2.20593446 |
| 160 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.20265575 |
| 161 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.19870361 |
| 162 | chondrocyte development (GO:0002063) | 2.19038597 |
| 163 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.19001384 |
| 164 | sister chromatid segregation (GO:0000819) | 2.18866638 |
| 165 | negative regulation of fatty acid transport (GO:2000192) | 2.18350620 |
| 166 | midgut development (GO:0007494) | 2.17973013 |
| 167 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.17971391 |
| 168 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.17971391 |
| 169 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.17971391 |
| 170 | neurotransmitter transport (GO:0006836) | 2.17832043 |
| 171 | aspartate family amino acid catabolic process (GO:0009068) | 2.17772973 |
| 172 | stress granule assembly (GO:0034063) | 2.17300064 |
| 173 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.17249982 |
| 174 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.16610035 |
| 175 | sulfur amino acid catabolic process (GO:0000098) | 2.16309095 |
| 176 | nitrogen cycle metabolic process (GO:0071941) | 2.15758168 |
| 177 | regulation of neurotransmitter levels (GO:0001505) | 2.15193326 |
| 178 | histone H3-K9 demethylation (GO:0033169) | 2.14519024 |
| 179 | positive regulation of fibroblast migration (GO:0010763) | 2.13209694 |
| 180 | paraxial mesoderm development (GO:0048339) | 2.12798540 |
| 181 | protein ADP-ribosylation (GO:0006471) | 2.12500805 |
| 182 | cellular response to vitamin (GO:0071295) | 2.12062166 |
| 183 | interkinetic nuclear migration (GO:0022027) | 2.11428352 |
| 184 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.11337998 |
| 185 | cell-substrate adherens junction assembly (GO:0007045) | 2.10211709 |
| 186 | focal adhesion assembly (GO:0048041) | 2.10211709 |
| 187 | peptidyl-lysine dimethylation (GO:0018027) | 2.09610915 |
| 188 | regulation of plasminogen activation (GO:0010755) | 2.08496504 |
| 189 | substrate-dependent cell migration (GO:0006929) | 2.08403449 |
| 190 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.08338027 |
| 191 | wound healing, spreading of epidermal cells (GO:0035313) | 2.08199018 |
| 192 | histone H2B ubiquitination (GO:0033523) | 2.07313988 |
| 193 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.06599849 |
| 194 | metanephric mesenchyme development (GO:0072075) | 2.06339891 |
| 195 | bone trabecula formation (GO:0060346) | 2.05915072 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.76094873 |
| 2 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.60427149 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.40879700 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.02094135 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.88869162 |
| 6 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.86185466 |
| 7 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.85798448 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.47552804 |
| 9 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.43446078 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.29841091 |
| 11 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.29384167 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.23251828 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.18762523 |
| 14 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.18207881 |
| 15 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.17394501 |
| 16 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 2.15987461 |
| 17 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.10081019 |
| 18 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.07083308 |
| 19 | FUS_26573619_Chip-Seq_HEK293_Human | 2.04790122 |
| 20 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.02342687 |
| 21 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.96849013 |
| 22 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.95425347 |
| 23 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.95045291 |
| 24 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.92459683 |
| 25 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.88407212 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87653514 |
| 27 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.87132829 |
| 28 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.86406235 |
| 29 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.86114301 |
| 30 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.83109776 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.80359876 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.79498017 |
| 33 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.79441165 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.79266349 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.79266349 |
| 36 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.78498244 |
| 37 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.76524884 |
| 38 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74498188 |
| 39 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.72307758 |
| 40 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.71154200 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.70849107 |
| 42 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.69757376 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.68641309 |
| 44 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.62013562 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.60927607 |
| 46 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.59749073 |
| 47 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.55082815 |
| 48 | CJUN_26792858_Chip-Seq_BT549_Human | 1.52585394 |
| 49 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.52463966 |
| 50 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.52422374 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.48356995 |
| 52 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.46631113 |
| 53 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.45875156 |
| 54 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.44017757 |
| 55 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.44017757 |
| 56 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.42932931 |
| 57 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.42460124 |
| 58 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42036937 |
| 59 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.39824926 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.39125718 |
| 61 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.38500321 |
| 62 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.38383791 |
| 63 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.38336890 |
| 64 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.36184686 |
| 65 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35778202 |
| 66 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.35108214 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34015481 |
| 68 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33525790 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.33464092 |
| 70 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.33143174 |
| 71 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32658074 |
| 72 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.32461212 |
| 73 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.32461212 |
| 74 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.31680767 |
| 75 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.29380914 |
| 76 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.28330348 |
| 77 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.27731352 |
| 78 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.27419950 |
| 79 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.27355717 |
| 80 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.27147509 |
| 81 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.26462670 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25898376 |
| 83 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.25148908 |
| 84 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25004773 |
| 85 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.24984007 |
| 86 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.24505714 |
| 87 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.24327991 |
| 88 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.23950567 |
| 89 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.23467261 |
| 90 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.22452756 |
| 91 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22245975 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21627452 |
| 93 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21149444 |
| 94 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.21089656 |
| 95 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20418587 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.20401250 |
| 97 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20193254 |
| 98 | JUN_21703547_ChIP-Seq_K562_Human | 1.19566122 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19329278 |
| 100 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19215420 |
| 101 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.18288399 |
| 102 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.17088397 |
| 103 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16724641 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.16505329 |
| 105 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15362685 |
| 106 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14032262 |
| 107 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13952345 |
| 108 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.13465697 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12118537 |
| 110 | P300_19829295_ChIP-Seq_ESCs_Human | 1.11961632 |
| 111 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.11845913 |
| 112 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10854785 |
| 113 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.10750360 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.09288206 |
| 115 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09145253 |
| 116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09144991 |
| 117 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.08976516 |
| 118 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08928064 |
| 119 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.08299379 |
| 120 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.07975027 |
| 121 | EWS_26573619_Chip-Seq_HEK293_Human | 1.07765978 |
| 122 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07731898 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07650671 |
| 124 | * GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.06867387 |
| 125 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.06826868 |
| 126 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06572210 |
| 127 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.06432683 |
| 128 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05134565 |
| 129 | STAT3_23295773_ChIP-Seq_U87_Human | 1.04755402 |
| 130 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04469470 |
| 131 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03593746 |
| 132 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.02833880 |
| 133 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02183749 |
| 134 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.02131344 |
| 135 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02036994 |
| 136 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.00202658 |
| 137 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.99854797 |
| 138 | * AR_19668381_ChIP-Seq_PC3_Human | 0.99747837 |
| 139 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99644850 |
| 140 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.98497478 |
| 141 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.95895682 |
| 142 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.95645471 |
| 143 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.95622718 |
| 144 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.95229933 |
| 145 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94304480 |
| 146 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94234170 |
| 147 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.94175166 |
| 148 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.94027370 |
| 149 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.93819672 |
| 150 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.93727577 |
| 151 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92525113 |
| 152 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92511446 |
| 153 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.91726325 |
| 154 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91175276 |
| 155 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.90896022 |
| 156 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.90828684 |
| 157 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.90425652 |
| 158 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90297381 |
| 159 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.89051105 |
| 160 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88927073 |
| 161 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.88647881 |
| 162 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.88369104 |
| 163 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.88332185 |
| 164 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88009344 |
| 165 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.87990715 |
| 166 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.87421302 |
| 167 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.87265553 |
| 168 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.86828528 |
| 169 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86129678 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 5.36120551 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.56670758 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.25806366 |
| 4 | MP0005360_urolithiasis | 3.74978140 |
| 5 | MP0005275_abnormal_skin_tensile | 3.55530935 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 3.21988218 |
| 7 | MP0004272_abnormal_basement_membrane | 3.04435136 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.03512497 |
| 9 | MP0009780_abnormal_chondrocyte_physiolo | 2.96412886 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.88804191 |
| 11 | MP0004270_analgesia | 2.80419089 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 2.75362772 |
| 13 | MP0005365_abnormal_bile_salt | 2.64639625 |
| 14 | MP0003880_abnormal_central_pattern | 2.63939246 |
| 15 | MP0005503_abnormal_tendon_morphology | 2.54683641 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.47852504 |
| 17 | MP0003329_amyloid_beta_deposits | 2.45218301 |
| 18 | MP0003252_abnormal_bile_duct | 2.19779693 |
| 19 | MP0002063_abnormal_learning/memory/cond | 2.08319600 |
| 20 | MP0003566_abnormal_cell_adhesion | 2.07280243 |
| 21 | MP0009745_abnormal_behavioral_response | 2.05072250 |
| 22 | MP0003941_abnormal_skin_development | 1.99572627 |
| 23 | MP0003385_abnormal_body_wall | 1.99034924 |
| 24 | MP0006054_spinal_hemorrhage | 1.93697509 |
| 25 | MP0002064_seizures | 1.92578681 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.92164013 |
| 27 | MP0003705_abnormal_hypodermis_morpholog | 1.91909745 |
| 28 | MP0002909_abnormal_adrenal_gland | 1.91480868 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.90727974 |
| 30 | MP0002822_catalepsy | 1.88557248 |
| 31 | MP0001958_emphysema | 1.87240053 |
| 32 | MP0009046_muscle_twitch | 1.87001006 |
| 33 | MP0005409_darkened_coat_color | 1.86142267 |
| 34 | MP0003279_aneurysm | 1.80928034 |
| 35 | MP0001968_abnormal_touch/_nociception | 1.78849295 |
| 36 | MP0002060_abnormal_skin_morphology | 1.76240067 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.71991098 |
| 38 | MP0000604_amyloidosis | 1.70823520 |
| 39 | MP0003195_calcinosis | 1.66009688 |
| 40 | MP0002234_abnormal_pharynx_morphology | 1.60069829 |
| 41 | MP0002572_abnormal_emotion/affect_behav | 1.58751144 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.58295853 |
| 43 | MP0000013_abnormal_adipose_tissue | 1.55601269 |
| 44 | MP0003868_abnormal_feces_composition | 1.55003438 |
| 45 | MP0002734_abnormal_mechanical_nocicepti | 1.52572795 |
| 46 | MP0008057_abnormal_DNA_replication | 1.51710843 |
| 47 | MP0002009_preneoplasia | 1.50152497 |
| 48 | MP0003122_maternal_imprinting | 1.48259730 |
| 49 | MP0004130_abnormal_muscle_cell | 1.46319468 |
| 50 | MP0000579_abnormal_nail_morphology | 1.45112833 |
| 51 | MP0002272_abnormal_nervous_system | 1.44039334 |
| 52 | MP0003091_abnormal_cell_migration | 1.42132622 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.41912998 |
| 54 | MP0005167_abnormal_blood-brain_barrier | 1.41784921 |
| 55 | MP0000762_abnormal_tongue_morphology | 1.41066718 |
| 56 | MP0000566_synostosis | 1.40014011 |
| 57 | MP0002877_abnormal_melanocyte_morpholog | 1.37277978 |
| 58 | MP0002736_abnormal_nociception_after | 1.36869167 |
| 59 | MP0003633_abnormal_nervous_system | 1.36572583 |
| 60 | MP0001440_abnormal_grooming_behavior | 1.36155724 |
| 61 | MP0008058_abnormal_DNA_repair | 1.31532442 |
| 62 | MP0004858_abnormal_nervous_system | 1.31363242 |
| 63 | MP0004185_abnormal_adipocyte_glucose | 1.30151143 |
| 64 | MP0000428_abnormal_craniofacial_morphol | 1.29532371 |
| 65 | MP0001348_abnormal_lacrimal_gland | 1.28478349 |
| 66 | MP0001661_extended_life_span | 1.27455467 |
| 67 | MP0002118_abnormal_lipid_homeostasis | 1.27025834 |
| 68 | MP0002733_abnormal_thermal_nociception | 1.26164726 |
| 69 | MP0005332_abnormal_amino_acid | 1.25736143 |
| 70 | MP0003115_abnormal_respiratory_system | 1.24412671 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 1.21881904 |
| 72 | MP0005083_abnormal_biliary_tract | 1.20774685 |
| 73 | MP0003221_abnormal_cardiomyocyte_apopto | 1.19730651 |
| 74 | MP0001915_intracranial_hemorrhage | 1.18420918 |
| 75 | MP0000767_abnormal_smooth_muscle | 1.16968763 |
| 76 | MP0001486_abnormal_startle_reflex | 1.15299346 |
| 77 | MP0004134_abnormal_chest_morphology | 1.14950966 |
| 78 | MP0005386_behavior/neurological_phenoty | 1.14646779 |
| 79 | MP0004924_abnormal_behavior | 1.14646779 |
| 80 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13877803 |
| 81 | MP0000920_abnormal_myelination | 1.13354562 |
| 82 | MP0004233_abnormal_muscle_weight | 1.12157636 |
| 83 | MP0000778_abnormal_nervous_system | 1.11577723 |
| 84 | MP0004811_abnormal_neuron_physiology | 1.11428363 |
| 85 | MP0008961_abnormal_basal_metabolism | 1.11177491 |
| 86 | MP0002108_abnormal_muscle_morphology | 1.10124556 |
| 87 | MP0001666_abnormal_nutrient_absorption | 1.08609842 |
| 88 | MP0002138_abnormal_hepatobiliary_system | 1.08565181 |
| 89 | MP0003935_abnormal_craniofacial_develop | 1.08369754 |
| 90 | MP0002067_abnormal_sensory_capabilities | 1.08100559 |
| 91 | MP0003303_peritoneal_inflammation | 1.07458104 |
| 92 | MP0008874_decreased_physiological_sensi | 1.06260043 |
| 93 | MP0003045_fibrosis | 1.06032654 |
| 94 | MP0003631_nervous_system_phenotype | 1.05287341 |
| 95 | MP0003755_abnormal_palate_morphology | 1.05106283 |
| 96 | MP0009697_abnormal_copulation | 1.04849490 |
| 97 | MP0000003_abnormal_adipose_tissue | 1.02837697 |
| 98 | MP0009053_abnormal_anal_canal | 1.02591441 |
| 99 | MP0009384_cardiac_valve_regurgitation | 1.02572776 |
| 100 | MP0008569_lethality_at_weaning | 1.02529136 |
| 101 | MP0005535_abnormal_body_temperature | 1.01999930 |
| 102 | MP0004885_abnormal_endolymph | 1.01814198 |
| 103 | MP0003690_abnormal_glial_cell | 1.01486204 |
| 104 | MP0003283_abnormal_digestive_organ | 0.99889169 |
| 105 | MP0002396_abnormal_hematopoietic_system | 0.99428480 |
| 106 | MP0000733_abnormal_muscle_development | 0.99077008 |
| 107 | MP0003075_altered_response_to | 0.98693030 |
| 108 | MP0003950_abnormal_plasma_membrane | 0.98384053 |
| 109 | MP0000955_abnormal_spinal_cord | 0.98095540 |
| 110 | MP0008007_abnormal_cellular_replicative | 0.97335178 |
| 111 | MP0003172_abnormal_lysosome_physiology | 0.97288399 |
| 112 | MP0000759_abnormal_skeletal_muscle | 0.96171174 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.95763824 |
| 114 | MP0005623_abnormal_meninges_morphology | 0.95540078 |
| 115 | MP0002114_abnormal_axial_skeleton | 0.95356401 |
| 116 | MP0010094_abnormal_chromosome_stability | 0.94890822 |
| 117 | MP0001970_abnormal_pain_threshold | 0.94556626 |
| 118 | MP0000534_abnormal_ureter_morphology | 0.94495263 |
| 119 | MP0003879_abnormal_hair_cell | 0.93994501 |
| 120 | MP0002876_abnormal_thyroid_physiology | 0.93496941 |
| 121 | MP0004197_abnormal_fetal_growth/weight/ | 0.93012526 |
| 122 | MP0001730_embryonic_growth_arrest | 0.92775160 |
| 123 | MP0002084_abnormal_developmental_patter | 0.92522048 |
| 124 | MP0001188_hyperpigmentation | 0.92469320 |
| 125 | MP0000569_abnormal_digit_pigmentation | 0.92440608 |
| 126 | MP0003300_gastrointestinal_ulcer | 0.92389411 |
| 127 | MP0003942_abnormal_urinary_system | 0.92081012 |
| 128 | MP0000751_myopathy | 0.91531483 |
| 129 | MP0001177_atelectasis | 0.91048035 |
| 130 | MP0003937_abnormal_limbs/digits/tail_de | 0.90069759 |
| 131 | MP0002066_abnormal_motor_capabilities/c | 0.89459522 |
| 132 | MP0002184_abnormal_innervation | 0.89053985 |
| 133 | MP0000609_abnormal_liver_physiology | 0.89023670 |
| 134 | MP0004043_abnormal_pH_regulation | 0.88339613 |
| 135 | MP0003121_genomic_imprinting | 0.88295605 |
| 136 | MP0002269_muscular_atrophy | 0.88289045 |
| 137 | MP0000432_abnormal_head_morphology | 0.86878999 |
| 138 | MP0009250_abnormal_appendicular_skeleto | 0.86656042 |
| 139 | MP0005076_abnormal_cell_differentiation | 0.86272296 |
| 140 | MP0010678_abnormal_skin_adnexa | 0.85860125 |
| 141 | MP0005621_abnormal_cell_physiology | 0.85529609 |
| 142 | MP0008932_abnormal_embryonic_tissue | 0.85100927 |
| 143 | MP0000462_abnormal_digestive_system | 0.84385050 |
| 144 | MP0000747_muscle_weakness | 0.84345516 |
| 145 | MP0002697_abnormal_eye_size | 0.84152380 |
| 146 | MP0001879_abnormal_lymphatic_vessel | 0.83989139 |
| 147 | MP0000350_abnormal_cell_proliferation | 0.83769165 |
| 148 | MP0000467_abnormal_esophagus_morphology | 0.83428537 |
| 149 | MP0002233_abnormal_nose_morphology | 0.83061053 |
| 150 | MP0001270_distended_abdomen | 0.83039896 |
| 151 | MP0001340_abnormal_eyelid_morphology | 0.82100242 |
| 152 | MP0001299_abnormal_eye_distance/ | 0.81561976 |
| 153 | MP0002090_abnormal_vision | 0.81435315 |
| 154 | MP0005023_abnormal_wound_healing | 0.81078517 |
| 155 | MP0005508_abnormal_skeleton_morphology | 0.80845322 |
| 156 | MP0001672_abnormal_embryogenesis/_devel | 0.80626008 |
| 157 | MP0005380_embryogenesis_phenotype | 0.80626008 |
| 158 | MP0003984_embryonic_growth_retardation | 0.80021926 |
| 159 | MP0002092_abnormal_eye_morphology | 0.79067937 |
| 160 | MP0002078_abnormal_glucose_homeostasis | 0.78767608 |
| 161 | MP0005187_abnormal_penis_morphology | 0.78726543 |
| 162 | MP0003890_abnormal_embryonic-extraembry | 0.77671940 |
| 163 | MP0010368_abnormal_lymphatic_system | 0.77665786 |
| 164 | MP0002086_abnormal_extraembryonic_tissu | 0.77118226 |
| 165 | MP0002088_abnormal_embryonic_growth/wei | 0.76312859 |
| 166 | MP0001243_abnormal_dermal_layer | 0.76077292 |
| 167 | MP0005645_abnormal_hypothalamus_physiol | 0.75604081 |
| 168 | MP0003111_abnormal_nucleus_morphology | 0.75282376 |
| 169 | MP0002081_perinatal_lethality | 0.73815010 |
| 170 | MP0001216_abnormal_epidermal_layer | 0.73767492 |
| 171 | MP0002557_abnormal_social/conspecific_i | 0.72488973 |
| 172 | MP0002896_abnormal_bone_mineralization | 0.72385965 |
| 173 | MP0003632_abnormal_nervous_system | 0.71785583 |
| 174 | MP0004484_altered_response_of | 0.69647577 |
| 175 | MP0005375_adipose_tissue_phenotype | 0.68964265 |
| 176 | MP0002109_abnormal_limb_morphology | 0.67948026 |
| 177 | MP0009840_abnormal_foam_cell | 0.67496115 |
| 178 | MP0001765_abnormal_ion_homeostasis | 0.67091557 |
| 179 | MP0002069_abnormal_eating/drinking_beha | 0.66492509 |
| 180 | MP0005166_decreased_susceptibility_to | 0.66062991 |
| 181 | MP0005319_abnormal_enzyme/_coenzyme | 0.66012232 |
| 182 | MP0004510_myositis | 0.65981516 |
| 183 | MP0002882_abnormal_neuron_morphology | 0.64367429 |
| 184 | MP0003634_abnormal_glial_cell | 0.61327330 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.33593242 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.26255420 |
| 3 | Atrophic scars (HP:0001075) | 4.25835824 |
| 4 | Premature rupture of membranes (HP:0001788) | 4.14401572 |
| 5 | Cerebral inclusion bodies (HP:0100314) | 3.75351553 |
| 6 | Neurofibrillary tangles (HP:0002185) | 3.44287999 |
| 7 | Focal motor seizures (HP:0011153) | 3.38247061 |
| 8 | Vascular tortuosity (HP:0004948) | 3.35380961 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 3.32153059 |
| 10 | Aortic dissection (HP:0002647) | 3.30434729 |
| 11 | Arterial tortuosity (HP:0005116) | 3.29420690 |
| 12 | Visual hallucinations (HP:0002367) | 3.22516529 |
| 13 | Papillary thyroid carcinoma (HP:0002895) | 3.19221623 |
| 14 | Supranuclear gaze palsy (HP:0000605) | 3.18709703 |
| 15 | Myokymia (HP:0002411) | 3.08033858 |
| 16 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.07819039 |
| 17 | Termporal pattern (HP:0011008) | 2.99727980 |
| 18 | Insidious onset (HP:0003587) | 2.99727980 |
| 19 | Xanthomatosis (HP:0000991) | 2.99127177 |
| 20 | Focal seizures (HP:0007359) | 2.96339426 |
| 21 | Fragile skin (HP:0001030) | 2.95448753 |
| 22 | Hyperventilation (HP:0002883) | 2.93311104 |
| 23 | Complement deficiency (HP:0004431) | 2.93148602 |
| 24 | Papilledema (HP:0001085) | 2.86071017 |
| 25 | Ankle contracture (HP:0006466) | 2.84083447 |
| 26 | Back pain (HP:0003418) | 2.82070824 |
| 27 | Atonic seizures (HP:0010819) | 2.78885443 |
| 28 | Absence seizures (HP:0002121) | 2.77616506 |
| 29 | Asymmetry of the thorax (HP:0001555) | 2.65214537 |
| 30 | Aortic aneurysm (HP:0004942) | 2.54223356 |
| 31 | Ketoacidosis (HP:0001993) | 2.53960816 |
| 32 | Bladder diverticulum (HP:0000015) | 2.53008009 |
| 33 | Epidermoid cyst (HP:0200040) | 2.52987597 |
| 34 | Soft skin (HP:0000977) | 2.51319269 |
| 35 | Ketosis (HP:0001946) | 2.49822622 |
| 36 | Bowel diverticulosis (HP:0005222) | 2.48181848 |
| 37 | Intention tremor (HP:0002080) | 2.47243198 |
| 38 | Wormian bones (HP:0002645) | 2.47218395 |
| 39 | Hyperlipoproteinemia (HP:0010980) | 2.47144475 |
| 40 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.46988663 |
| 41 | Action tremor (HP:0002345) | 2.45408955 |
| 42 | Hypobetalipoproteinemia (HP:0003563) | 2.44595163 |
| 43 | Mitral stenosis (HP:0001718) | 2.43570458 |
| 44 | Pheochromocytoma (HP:0002666) | 2.42313306 |
| 45 | Abnormality of the corticospinal tract (HP:0002492) | 2.37729255 |
| 46 | Neonatal short-limb short stature (HP:0008921) | 2.34012448 |
| 47 | Abnormality of the common coagulation pathway (HP:0010990) | 2.29963788 |
| 48 | Milia (HP:0001056) | 2.29641415 |
| 49 | Epileptic encephalopathy (HP:0200134) | 2.29171627 |
| 50 | Dialeptic seizures (HP:0011146) | 2.28051302 |
| 51 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.27540608 |
| 52 | Cerebral hemorrhage (HP:0001342) | 2.27104412 |
| 53 | Abnormality of the lower motor neuron (HP:0002366) | 2.24185970 |
| 54 | Relative macrocephaly (HP:0004482) | 2.23075735 |
| 55 | Impaired social interactions (HP:0000735) | 2.22854910 |
| 56 | Abnormal social behavior (HP:0012433) | 2.22854910 |
| 57 | Macroorchidism (HP:0000053) | 2.22528932 |
| 58 | Generalized tonic-clonic seizures (HP:0002069) | 2.22160505 |
| 59 | Vertebral arch anomaly (HP:0008438) | 2.21847636 |
| 60 | Abnormality of the Achilles tendon (HP:0005109) | 2.21522699 |
| 61 | Postural instability (HP:0002172) | 2.20533535 |
| 62 | Dysmetria (HP:0001310) | 2.18789498 |
| 63 | Entropion (HP:0000621) | 2.18769379 |
| 64 | Excessive salivation (HP:0003781) | 2.17109631 |
| 65 | Drooling (HP:0002307) | 2.17109631 |
| 66 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.16068659 |
| 67 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.16068659 |
| 68 | Prolonged partial thromboplastin time (HP:0003645) | 2.15686340 |
| 69 | Breech presentation (HP:0001623) | 2.14040525 |
| 70 | Abnormality of dentin (HP:0010299) | 2.13878287 |
| 71 | Lower limb muscle weakness (HP:0007340) | 2.13369343 |
| 72 | Delayed CNS myelination (HP:0002188) | 2.11440816 |
| 73 | Broad palm (HP:0001169) | 2.11154526 |
| 74 | Mitral valve prolapse (HP:0001634) | 2.11081251 |
| 75 | Heterotopia (HP:0002282) | 2.10017941 |
| 76 | Limb-girdle muscle weakness (HP:0003325) | 2.09797561 |
| 77 | Mild short stature (HP:0003502) | 2.09665850 |
| 78 | Long clavicles (HP:0000890) | 2.05958826 |
| 79 | Urinary urgency (HP:0000012) | 2.04085771 |
| 80 | Skin nodule (HP:0200036) | 2.04085257 |
| 81 | Poor eye contact (HP:0000817) | 2.03244266 |
| 82 | Spinal rigidity (HP:0003306) | 2.02280086 |
| 83 | Buphthalmos (HP:0000557) | 2.02047015 |
| 84 | Cortical dysplasia (HP:0002539) | 2.02026387 |
| 85 | Scanning speech (HP:0002168) | 2.01474087 |
| 86 | Abnormality of the calcaneus (HP:0008364) | 2.01379003 |
| 87 | Dysdiadochokinesis (HP:0002075) | 2.00870899 |
| 88 | Agitation (HP:0000713) | 1.99873571 |
| 89 | Torticollis (HP:0000473) | 1.97960568 |
| 90 | Thyroid carcinoma (HP:0002890) | 1.97335342 |
| 91 | Pelvic girdle muscle weakness (HP:0003749) | 1.97110482 |
| 92 | Epileptiform EEG discharges (HP:0011182) | 1.96673458 |
| 93 | EEG with generalized epileptiform discharges (HP:0011198) | 1.96286127 |
| 94 | Spontaneous abortion (HP:0005268) | 1.95336002 |
| 95 | Ankyloglossia (HP:0010296) | 1.94874573 |
| 96 | Rhizomelia (HP:0008905) | 1.93951607 |
| 97 | Depression (HP:0000716) | 1.93880699 |
| 98 | Status epilepticus (HP:0002133) | 1.93443764 |
| 99 | Overgrowth (HP:0001548) | 1.93109662 |
| 100 | Neonatal onset (HP:0003623) | 1.93012962 |
| 101 | Shoulder girdle muscle weakness (HP:0003547) | 1.93004226 |
| 102 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.92593522 |
| 103 | Natal tooth (HP:0000695) | 1.92140305 |
| 104 | Anxiety (HP:0000739) | 1.91310685 |
| 105 | Neuroendocrine neoplasm (HP:0100634) | 1.90812645 |
| 106 | Truncal ataxia (HP:0002078) | 1.90632305 |
| 107 | Achilles tendon contracture (HP:0001771) | 1.90387029 |
| 108 | Abnormality of complement system (HP:0005339) | 1.90045215 |
| 109 | Hypsarrhythmia (HP:0002521) | 1.89050511 |
| 110 | Spastic diplegia (HP:0001264) | 1.88868143 |
| 111 | Abnormal gallbladder physiology (HP:0012438) | 1.88735534 |
| 112 | Cholecystitis (HP:0001082) | 1.88735534 |
| 113 | Joint laxity (HP:0001388) | 1.88339686 |
| 114 | Amblyopia (HP:0000646) | 1.87726753 |
| 115 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.87431827 |
| 116 | Knee flexion contracture (HP:0006380) | 1.87431513 |
| 117 | Subacute progressive viral hepatitis (HP:0006572) | 1.87372901 |
| 118 | Aplasia cutis congenita (HP:0001057) | 1.87189870 |
| 119 | Hypolipoproteinemia (HP:0010981) | 1.87089195 |
| 120 | Global brain atrophy (HP:0002283) | 1.86208415 |
| 121 | Cubitus valgus (HP:0002967) | 1.86058805 |
| 122 | Dilatation of the ascending aorta (HP:0005111) | 1.86052453 |
| 123 | Onycholysis (HP:0001806) | 1.86025895 |
| 124 | Resting tremor (HP:0002322) | 1.85446367 |
| 125 | Type 1 muscle fiber predominance (HP:0003803) | 1.84855079 |
| 126 | Abnormal foot bone ossification (HP:0010675) | 1.84512309 |
| 127 | Spastic gait (HP:0002064) | 1.83847620 |
| 128 | Progressive cerebellar ataxia (HP:0002073) | 1.82722248 |
| 129 | Ankle clonus (HP:0011448) | 1.82693748 |
| 130 | Hyperammonemia (HP:0001987) | 1.82267172 |
| 131 | Fragile nails (HP:0001808) | 1.81718414 |
| 132 | Syringomyelia (HP:0003396) | 1.79207592 |
| 133 | Spinal cord lesions (HP:0100561) | 1.79207592 |
| 134 | Gout (HP:0001997) | 1.78526725 |
| 135 | Hypoplastic nipples (HP:0002557) | 1.77691539 |
| 136 | Hemiplegia (HP:0002301) | 1.77524503 |
| 137 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.76689262 |
| 138 | Broad-based gait (HP:0002136) | 1.75799259 |
| 139 | Sensorimotor neuropathy (HP:0007141) | 1.75539973 |
| 140 | Striae distensae (HP:0001065) | 1.75371637 |
| 141 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.74700991 |
| 142 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.74700991 |
| 143 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.74667853 |
| 144 | Hypoplasia of the iris (HP:0007676) | 1.74584748 |
| 145 | Generalized myoclonic seizures (HP:0002123) | 1.74410190 |
| 146 | Abnormality of the intrinsic pathway (HP:0010989) | 1.74341352 |
| 147 | Cutaneous melanoma (HP:0012056) | 1.74317596 |
| 148 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.74253866 |
| 149 | Hypoalphalipoproteinemia (HP:0003233) | 1.74198724 |
| 150 | Rapidly progressive (HP:0003678) | 1.73486306 |
| 151 | Calcaneovalgus deformity (HP:0001848) | 1.73270461 |
| 152 | Limb-girdle muscle atrophy (HP:0003797) | 1.73075420 |
| 153 | Ulnar bowing (HP:0003031) | 1.72221417 |
| 154 | Mesomelia (HP:0003027) | 1.72186363 |
| 155 | Decreased skull ossification (HP:0004331) | 1.71984800 |
| 156 | Craniofacial dystonia (HP:0012179) | 1.71536203 |
| 157 | Facial hemangioma (HP:0000329) | 1.71524001 |
| 158 | Follicular hyperkeratosis (HP:0007502) | 1.71174339 |
| 159 | Hypercortisolism (HP:0001578) | 1.69790951 |
| 160 | Dysmetric saccades (HP:0000641) | 1.69655725 |
| 161 | Abnormal delivery (HP:0001787) | 1.69476558 |
| 162 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.69134625 |
| 163 | Complete atrioventricular canal defect (HP:0001674) | 1.69109141 |
| 164 | Akinesia (HP:0002304) | 1.69078096 |
| 165 | Focal dystonia (HP:0004373) | 1.68543429 |
| 166 | Abnormality of skull ossification (HP:0002703) | 1.68319449 |
| 167 | Lymphangioma (HP:0100764) | 1.68310360 |
| 168 | Hammertoe (HP:0001765) | 1.67701900 |
| 169 | Lower limb amyotrophy (HP:0007210) | 1.67701279 |
| 170 | Poikiloderma (HP:0001029) | 1.67520614 |
| 171 | Neuronal loss in central nervous system (HP:0002529) | 1.66853401 |
| 172 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.66783559 |
| 173 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.65786081 |
| 174 | Osteolytic defects of the hand bones (HP:0009699) | 1.65786081 |
| 175 | Aneurysm (HP:0002617) | 1.65498193 |
| 176 | Abnormality of the acetabulum (HP:0003170) | 1.65141848 |
| 177 | Overlapping toe (HP:0001845) | 1.65008627 |
| 178 | Autoamputation (HP:0001218) | 1.64959968 |
| 179 | Spondylolisthesis (HP:0003302) | 1.63636828 |
| 180 | Volvulus (HP:0002580) | 1.61722854 |
| 181 | Capillary hemangiomas (HP:0005306) | 1.61307576 |
| 182 | Flat acetabular roof (HP:0003180) | 1.61146943 |
| 183 | Metatarsus adductus (HP:0001840) | 1.60181467 |
| 184 | Wide anterior fontanel (HP:0000260) | 1.59616975 |
| 185 | Large earlobe (HP:0009748) | 1.59272066 |
| 186 | Shallow orbits (HP:0000586) | 1.56479890 |
| 187 | Hyperextensible skin (HP:0000974) | 1.55910625 |
| 188 | Cystic hygroma (HP:0000476) | 1.54774458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.49316051 |
| 2 | NTRK3 | 2.89991378 |
| 3 | AKT3 | 2.85151305 |
| 4 | NEK9 | 2.69704400 |
| 5 | EPHA4 | 2.66978104 |
| 6 | MAP3K4 | 2.54101273 |
| 7 | MAP2K4 | 2.47939749 |
| 8 | MINK1 | 2.34128010 |
| 9 | MARK1 | 2.25530537 |
| 10 | KSR2 | 2.24440418 |
| 11 | ERBB3 | 2.18796291 |
| 12 | BRD4 | 1.99577188 |
| 13 | PKN2 | 1.98897070 |
| 14 | RIPK4 | 1.97247126 |
| 15 | EIF2AK3 | 1.97013526 |
| 16 | NTRK1 | 1.95796516 |
| 17 | RIPK1 | 1.81087029 |
| 18 | PRKD3 | 1.79421153 |
| 19 | DAPK2 | 1.75277762 |
| 20 | RET | 1.71104944 |
| 21 | MAP3K2 | 1.62359268 |
| 22 | PAK6 | 1.61447507 |
| 23 | EEF2K | 1.60603183 |
| 24 | MAP3K13 | 1.58702184 |
| 25 | MAP3K12 | 1.57890609 |
| 26 | FGFR2 | 1.56180801 |
| 27 | PNCK | 1.52931536 |
| 28 | SCYL2 | 1.48822664 |
| 29 | TTN | 1.48662999 |
| 30 | BRSK2 | 1.45608265 |
| 31 | CAMKK1 | 1.45097953 |
| 32 | RAF1 | 1.42949086 |
| 33 | ICK | 1.38597423 |
| 34 | CDK12 | 1.36245747 |
| 35 | FRK | 1.35644267 |
| 36 | SRPK1 | 1.33312443 |
| 37 | TRIB3 | 1.31339827 |
| 38 | KSR1 | 1.31239771 |
| 39 | PAK3 | 1.30166320 |
| 40 | CLK1 | 1.25923543 |
| 41 | PAK2 | 1.23415011 |
| 42 | CAMK1G | 1.22745068 |
| 43 | EPHB2 | 1.21363989 |
| 44 | SIK2 | 1.19078450 |
| 45 | PLK2 | 1.18732369 |
| 46 | LATS2 | 1.18049717 |
| 47 | PRKCH | 1.17907598 |
| 48 | MAP2K7 | 1.16035299 |
| 49 | CDK5 | 1.13145388 |
| 50 | CDK6 | 1.09690171 |
| 51 | FER | 1.08712930 |
| 52 | WNK4 | 1.06392587 |
| 53 | OXSR1 | 1.05701298 |
| 54 | FLT3 | 1.05093028 |
| 55 | SIK1 | 0.98780060 |
| 56 | DAPK1 | 0.96595094 |
| 57 | NEK2 | 0.96298390 |
| 58 | MAP3K7 | 0.95119045 |
| 59 | STK38L | 0.92804157 |
| 60 | WNK1 | 0.92154473 |
| 61 | STK39 | 0.90866764 |
| 62 | PTK6 | 0.90858244 |
| 63 | CASK | 0.90665291 |
| 64 | TRPM7 | 0.90323712 |
| 65 | PIK3CA | 0.90213451 |
| 66 | STK11 | 0.90212435 |
| 67 | MAP3K10 | 0.90172017 |
| 68 | PTK2B | 0.87568769 |
| 69 | PBK | 0.85726783 |
| 70 | ERN1 | 0.85084800 |
| 71 | PDGFRA | 0.84751000 |
| 72 | MAP3K1 | 0.84438534 |
| 73 | FGFR4 | 0.84413592 |
| 74 | MKNK1 | 0.83819543 |
| 75 | RPS6KB1 | 0.83620292 |
| 76 | ALK | 0.82568711 |
| 77 | CSNK1G2 | 0.79015976 |
| 78 | TTK | 0.78773942 |
| 79 | CDK3 | 0.78453644 |
| 80 | FES | 0.77801201 |
| 81 | TYRO3 | 0.77670592 |
| 82 | PDK1 | 0.77002501 |
| 83 | FGFR3 | 0.76896635 |
| 84 | PDPK1 | 0.76217686 |
| 85 | SGK2 | 0.76100722 |
| 86 | WEE1 | 0.73627955 |
| 87 | GRK6 | 0.72610522 |
| 88 | PDK4 | 0.72520873 |
| 89 | PDK3 | 0.72520873 |
| 90 | PTK2 | 0.72408556 |
| 91 | BCR | 0.72018090 |
| 92 | MYLK | 0.71476763 |
| 93 | CAMKK2 | 0.71101031 |
| 94 | TAOK1 | 0.69468216 |
| 95 | SGK3 | 0.68777863 |
| 96 | MAP3K6 | 0.68275892 |
| 97 | PRKCG | 0.68047205 |
| 98 | MAP2K1 | 0.67759738 |
| 99 | CAMK2A | 0.66912263 |
| 100 | FGR | 0.66184246 |
| 101 | ROCK2 | 0.65277025 |
| 102 | MST1R | 0.64405918 |
| 103 | LIMK1 | 0.63642876 |
| 104 | MAPKAPK5 | 0.63095356 |
| 105 | NEK1 | 0.61896437 |
| 106 | PIK3CG | 0.61731912 |
| 107 | GRK5 | 0.61729893 |
| 108 | CDK14 | 0.61068751 |
| 109 | DDR2 | 0.60812376 |
| 110 | STK38 | 0.60084336 |
| 111 | PRKCZ | 0.59627400 |
| 112 | CDK19 | 0.57795355 |
| 113 | FYN | 0.57350864 |
| 114 | CSNK1A1L | 0.56975291 |
| 115 | TSSK6 | 0.56715086 |
| 116 | RPS6KB2 | 0.56683254 |
| 117 | CDC7 | 0.55899583 |
| 118 | MET | 0.55458480 |
| 119 | SGK1 | 0.55379330 |
| 120 | MAPK12 | 0.54326126 |
| 121 | UHMK1 | 0.51065339 |
| 122 | ATM | 0.50754567 |
| 123 | MAP3K5 | 0.50526752 |
| 124 | ERBB4 | 0.50124227 |
| 125 | MAPK10 | 0.49924877 |
| 126 | DMPK | 0.49746268 |
| 127 | JAK1 | 0.49640981 |
| 128 | PDGFRB | 0.49596572 |
| 129 | CSF1R | 0.49026847 |
| 130 | CCNB1 | 0.48871543 |
| 131 | CHEK1 | 0.48821283 |
| 132 | CAMK2B | 0.48728827 |
| 133 | PRKCQ | 0.48138699 |
| 134 | PHKG2 | 0.47414789 |
| 135 | PHKG1 | 0.47414789 |
| 136 | SGK223 | 0.47112891 |
| 137 | SGK494 | 0.47112891 |
| 138 | PLK1 | 0.46839508 |
| 139 | CDK11A | 0.46705645 |
| 140 | INSRR | 0.46602446 |
| 141 | CDK15 | 0.46381326 |
| 142 | MELK | 0.45909507 |
| 143 | CDK18 | 0.45909385 |
| 144 | PRKCE | 0.45207933 |
| 145 | CSNK1E | 0.45180316 |
| 146 | EPHB1 | 0.44877053 |
| 147 | LATS1 | 0.44698510 |
| 148 | MTOR | 0.42407382 |
| 149 | MAP3K14 | 0.42007900 |
| 150 | STK3 | 0.40983878 |
| 151 | CDK9 | 0.40819496 |
| 152 | BRSK1 | 0.40440083 |
| 153 | PAK4 | 0.39660074 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.99967219 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.81987491 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.28030209 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.27188157 |
| 5 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.15828297 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.05885813 |
| 7 | Focal adhesion_Homo sapiens_hsa04510 | 2.00859205 |
| 8 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.98435072 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 1.89405365 |
| 10 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.66673023 |
| 11 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.66645770 |
| 12 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.63236321 |
| 13 | Adherens junction_Homo sapiens_hsa04520 | 1.61867207 |
| 14 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.60229528 |
| 15 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.59922475 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.57238642 |
| 17 | Nicotine addiction_Homo sapiens_hsa05033 | 1.55176692 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.52039834 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.51694306 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.50928561 |
| 21 | Circadian entrainment_Homo sapiens_hsa04713 | 1.50694354 |
| 22 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.49469244 |
| 23 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.47200329 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.44786029 |
| 25 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.44589710 |
| 26 | Endometrial cancer_Homo sapiens_hsa05213 | 1.43548289 |
| 27 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.43235562 |
| 28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.42054786 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.41680969 |
| 30 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.41261592 |
| 31 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.40509133 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.38855102 |
| 33 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.38483715 |
| 34 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.37985465 |
| 35 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.35557330 |
| 36 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.34784036 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.33344469 |
| 38 | Renin secretion_Homo sapiens_hsa04924 | 1.33282991 |
| 39 | Salivary secretion_Homo sapiens_hsa04970 | 1.31892101 |
| 40 | Colorectal cancer_Homo sapiens_hsa05210 | 1.31854241 |
| 41 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.31795319 |
| 42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.30922512 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29802168 |
| 44 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.27852485 |
| 45 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.25234397 |
| 46 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.24982473 |
| 47 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.24712609 |
| 48 | Morphine addiction_Homo sapiens_hsa05032 | 1.23834936 |
| 49 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.23778824 |
| 50 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.23111029 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22167990 |
| 52 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.21897984 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 1.20540382 |
| 54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.18858942 |
| 55 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.18480067 |
| 56 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.17947885 |
| 57 | Insulin secretion_Homo sapiens_hsa04911 | 1.17515632 |
| 58 | Thyroid cancer_Homo sapiens_hsa05216 | 1.16434329 |
| 59 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.15224246 |
| 60 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.15030536 |
| 61 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.14595264 |
| 62 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.13100871 |
| 63 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.12980609 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 1.12036013 |
| 65 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.11669631 |
| 66 | Olfactory transduction_Homo sapiens_hsa04740 | 1.11116139 |
| 67 | Prostate cancer_Homo sapiens_hsa05215 | 1.10521190 |
| 68 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09148121 |
| 69 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.09023802 |
| 70 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.08866787 |
| 71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.06783742 |
| 72 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.05811406 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.05492969 |
| 74 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 1.03476240 |
| 75 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02258999 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.00394182 |
| 77 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.99769185 |
| 78 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96125345 |
| 79 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.95696830 |
| 80 | Glioma_Homo sapiens_hsa05214 | 0.95612342 |
| 81 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.95581095 |
| 82 | Pathways in cancer_Homo sapiens_hsa05200 | 0.94823981 |
| 83 | Cocaine addiction_Homo sapiens_hsa05030 | 0.94701372 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.94433095 |
| 85 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.93756750 |
| 86 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92914998 |
| 87 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92835231 |
| 88 | Melanoma_Homo sapiens_hsa05218 | 0.92694180 |
| 89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87043674 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.86275946 |
| 91 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.86185089 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.85244876 |
| 93 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.84599580 |
| 94 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.81010276 |
| 95 | Gap junction_Homo sapiens_hsa04540 | 0.80786300 |
| 96 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.80572011 |
| 97 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80364253 |
| 98 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78171461 |
| 99 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.77901953 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77519549 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.75313938 |
| 102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.74956677 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74751161 |
| 104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.74541847 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.73134791 |
| 106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.70291257 |
| 107 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.70044838 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.68553409 |
| 109 | Axon guidance_Homo sapiens_hsa04360 | 0.67797630 |
| 110 | RNA transport_Homo sapiens_hsa03013 | 0.66824731 |
| 111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66088951 |
| 112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.64624410 |
| 113 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.64212972 |
| 114 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63587308 |
| 115 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62482418 |
| 116 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61635760 |
| 117 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60840821 |
| 118 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59462493 |
| 119 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.57815259 |
| 120 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57786085 |
| 121 | Taste transduction_Homo sapiens_hsa04742 | 0.57392395 |
| 122 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57246712 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56152654 |
| 124 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.55440744 |
| 125 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.55170238 |
| 126 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.54171135 |
| 127 | Peroxisome_Homo sapiens_hsa04146 | 0.53918371 |
| 128 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.53740296 |
| 129 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53621557 |
| 130 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.53505328 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | 0.53298559 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53212662 |
| 133 | Melanogenesis_Homo sapiens_hsa04916 | 0.52855276 |
| 134 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.52781934 |
| 135 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52772307 |
| 136 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52192604 |
| 137 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49567816 |
| 138 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49490077 |
| 139 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.49041901 |
| 140 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.47438686 |
| 141 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47436132 |
| 142 | Endocytosis_Homo sapiens_hsa04144 | 0.46483979 |
| 143 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45457730 |
| 144 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45306623 |
| 145 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.45151981 |
| 146 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.44668455 |
| 147 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43593338 |
| 148 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.43428622 |
| 149 | ABC transporters_Homo sapiens_hsa02010 | 0.43035593 |
| 150 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.41745492 |
| 151 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41510162 |
| 152 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39137312 |
| 153 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.38621740 |
| 154 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.37487562 |
| 155 | Platelet activation_Homo sapiens_hsa04611 | 0.36820226 |
| 156 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.36504207 |

